facebook twitter youtube
Caliber I.D. Board of Directors

L. Michael Hone

Director and Chief Executive Officer

Mr. Hone was elected to the Board in 2002. He joined Caliber I.D. (then Lucid, Inc.) as executive vice president in 2011 and was charged with corporate strategic planning to support the adoption of Caliber I.D.’s technologies into the mainstream continuum of care. In December 2011, he became chief executive officer (CEO). From June 2008 through August 2010, Mr. Hone served as president, CEO, and director of American Aerogel. From 2006 through 2008, he was a consultant for Tempus Partners, a business-consulting firm of which he was the sole owner. From 2001 to 2005, Mr. Hone served as president and chief operating officer of Conseco, Inc. during which time he helped guide this financial services firm through the bankruptcy and restructuring process. He also served as president and CEO of Centennial Technologies, a manufacturer of digital memory that has since been acquired by another entity, and president, CEO, and chairman of PSC, Inc., an Auto ID manufacturer of digital memory. Both were public companies traded on Nasdaq. Mr. Hone is a named inventor or co-inventor on seven patents. He also currently serves as director for Chairman’s View, Inc. (Boston, MA) and as chairman of the board of trustees at the Killington Mountain School (Killington, VT).

 

Richard C. Christopher

Chief Financial Officer

Richard C. Christopher joined Caliber I.D. as Chief Financial Officer in March 2014. Previously, he served for eight years as Chief Financial Officer of DUSA Pharmaceuticals, Inc., a vertically integrated specialty dermatology company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy technology platform for the treatment of precancerous skin lesions. Mr. Christopher arrived at DUSA in 2000 and held a series of positions of increasing responsibility before assuming the CFO role in January 2005. He was instrumental in migrating this publicly traded company from operational infancy, through commercialization and profitability, to its eventual sale. In December 2012, he oversaw the sale of DUSA Pharmaceuticals to Sun Pharmaceuticals for $230 million, a 38 percent premium to market. Mr. Christopher holds a masters of science degree in accounting from Suffolk University in Boston and a bachelor of science degree in finance from Bentley College in Waltham, Massachusetts.

Robert T. Kelley

Vice President of U.S. Sales

Mr. Kelley was promoted to Vice President of U.S. Sales in March 2014, and oversees the development and execution of strategies that are designed to strengthen recognition and maximize sales of Caliber I.D.’s VivaScope® products and technologies. Since joining the company in November 2011, he has served as Caliber I.D.’s Director of Clinical Sales. Mr. Kelley has nearly two decades of experience in medical sales, with expertise in capital medical equipment and a specialty in diagnostic imaging. Before arriving at Caliber I.D., he was Northeast Regional Territory Sales Manager at XHALE Corporation, where he oversaw sales of their hand hygiene systems and liaised with C-level healthcare personnel at a wide range of institutions. Previous to this he was Northeast Regional Territory Sales Manager at ONI Medical Systems (later acquired by GE Healthcare), where he oversaw sales of MRI systems to a range of healthcare facilities. Earlier, he served as Contrast Media and Delivery System Specialist for Covidien’s Tyco Healthcare and Mallinckrodt divisions. Prior to this, he held sales and marketing positions at Radiology Corporation of America and Medical Resources. Mr. Kelley holds a BS degree in pre-medicine with an emphasis in medical therapeutic science and rehabilitation from Springfield College.

William J. Fox

Vice President, Technology Operations

Chief Technology Officer

As chief technology officer, Mr. Fox is responsible for Caliber I.D.’s engineering, research, and development operations. He joined the company in 1999, serving as engineering manager until his promotion to his current position in 2005. Prior to joining the company, Mr. Fox held product-engineering positions at Mitsui-Pathtek, Burron Medical, and Fisher Price. He currently manages teams that specialize in technologies such as video-rate confocal scanning laser microscopy and design/development of optics and electronic instrumentation. He holds inventor or co-inventor patents in confocal imaging head design and optical examination of tissue, along with instrumentation design and methodology.

Christi Alessi Fox

Vice President of Clinical Development

Ms. Alessi Fox joined the company in 1995 and has worked extensively with confocal experts worldwide on the development and implementation of the technology for both research and clinical practice. She is recognized as an expert in the confocal image interpretation and has co-authored several publications demonstrating the utility of confocal microscopy for dermatologic, neurologic, and surgical tissue applications. Ms. Alessi Fox holds a BS from the Rochester Institute of Technology and is a Certified Clinical Research Professional (CCRP). She is responsible for the implementation of the VivaScope and telepathology technologies into the workflow of clinical practices as well as the coordination of research studies.